Ciprofloxacin Hydrochloride And Hydrocortisone Suspension/ Drops
Product Images NDC 0781-6218

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin Hydrochloride And Hydrocortisone (NDC 0781-6218). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mlcarton (10mlcarton)

Packaging label for Ciprofloxacin 0.2% HCl and Hydrocortisone 1% Otic Suspension, 10 mL, by Sandoz Inc. The label states it is for prescription use only, auricular (otic) administration, and not for ophthalmic or oral use. Storage instructions and manufacturer details from Spain are included, along with warnings to shake well before use and keep out of reach of children.*

FDA Label Image

Ciprofloxacin Chemical Structure (Image 01)

Chemical structure diagram of ciprofloxacin hydrochloride, showing its molecular components including a fluorinated quinolone core, piperazine ring, and associated hydrochloride and water molecules.*

FDA Label Image

Hydrocortisone Chemical Structure (Image 02)

Chemical structure diagram of an active ingredient in ciprofloxacin hydrochloride and hydrocortisone suspension/drops, showing detailed molecular bonds and functional groups typical of hydrocortisone.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.